Ortho-Clinical Diagnostics Inc.:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】Ortho-Clinical Diagnostics Inc. Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 In Vitro Diagnostics 11
3.1.1 Clinical Chemistry 11
3.1.2 Immuno Chemistry 11
4 Company Snapshot 12
4.1 Key Information 12
4.2 Company Overview 12
4.3 SWOT Snapshot 12
4.4 Business Overview 13
4.5 Major Products and Services 14
4.5.1 Overview 14
5 History 15
6 SWOT Analysis 18
6.1 Overview 18
6.2 Ortho-Clinical Diagnostics Inc. Strengths 18
6.2.1 IVD Product Portfolio 18
6.2.2 Improving Market Share in Global IVD Segment 18
6.2.3 The VITROS Family of Systems 19
6.3 Ortho-Clinical Diagnostics Inc. Weaknesses 19
6.3.1 Product Recalls 19
6.4 Ortho-Clinical Diagnostics Inc. Opportunities 19
6.4.1 Public-Private Partnership: US and China 19
6.4.2 Product Pipeline and New Product Launches 19
6.4.3 Expansion Strategy 20
6.5 Ortho-Clinical Diagnostics Inc. Threats 20
6.5.1 Increasing Competition 20
6.5.2 Regulatory Environment 20
6.5.3 Evolving Technological Environment 20
7 Competitors 21
8 Competitive Landscape 22
8.1 In Vitro Diagnostics(Clinical Chemistry), Global, Market Share (%), 2011 22
8.2 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Clinical Chemistry)by Region, Market Share (2011) 23
8.3 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Clinical Chemistry), by Country, Market Share (2011) 24
8.4 In Vitro Diagnostics(Immuno Chemistry), Global, Market Share (%), 2011 26
8.5 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Immuno Chemistry), by Region, Market Share (2011) 28
8.6 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Immuno Chemistry), by Country, Market Share (2011) 29
9 Ortho-Clinical Diagnostics Inc Medical Equipment Market Share Analysis by Category 31
9.1 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics, Global, Category Revenue Share (2011) 31
9.2 Ortho-Clinical Diagnostics Inc., Asia-Pacific, Category Revenue Share (2011) 33
9.2.1 Ortho-Clinical Diagnostics Inc., Australia, Category Revenue Share (2011) 35
9.2.2 Ortho-Clinical Diagnostics Inc., China, Category Revenue Share (2011) 37
9.2.3 Ortho-Clinical Diagnostics Inc., India, Category Revenue Share (2011) 39
9.2.4 Ortho-Clinical Diagnostics Inc., Japan, Category Revenue Share (2011) 41
9.2.5 Ortho-Clinical Diagnostics Inc., Other Asia-Pacific, Category Revenue Share (2011) 43
9.3 Ortho-Clinical Diagnostics Inc., Europe, Category Revenue Share (2011) 45
9.3.1 Ortho-Clinical Diagnostics Inc., France, Category Revenue Share (2011) 47
9.3.2 Ortho-Clinical Diagnostics Inc., Germany, Category Revenue Share (2011) 49
9.3.3 Ortho-Clinical Diagnostics Inc., Italy, Category Revenue Share (2011) 51
9.3.4 Ortho-Clinical Diagnostics Inc., Spain, Category Revenue Share (2011) 53
9.3.5 Ortho-Clinical Diagnostics Inc., United Kingdom, Category Revenue Share (2011) 55
9.3.6 Ortho-Clinical Diagnostics Inc., Other Europe, Category Revenue Share (2011) 57
9.4 Ortho-Clinical Diagnostics Inc., Middle East and Africa, Category Revenue Share (2011) 58
9.5 Ortho-Clinical Diagnostics Inc., North America, Category Revenue Share (2011) 61
9.5.1 Ortho-Clinical Diagnostics Inc., Canada, Category Revenue Share (2011) 63
9.5.2 Ortho-Clinical Diagnostics Inc., United States, Category Revenue Share (2011) 65
9.6 Ortho-Clinical Diagnostics Inc., South and Central America, Category Revenue Share (2011) 67
9.6.1 Ortho-Clinical Diagnostics Inc., Brazil, Category Revenue Share (2011) 69
9.6.2 Ortho-Clinical Diagnostics Inc., Other South and Central America, Category Revenue Share (2011) 71
10 Key Employees 73
11 Company Statement 74
12 Locations And Subsidiaries 75
12.1 Head Office 75
12.2 Other Locations & Subsidiaries 75
13 Financial Deals Landscape 77
13.1 Ortho-Clinical Diagnostics Inc., Deals Volume Summary, 2007 to YTD 2013 77
14 Ortho-Clinical Diagnostics Inc. Detailed Deal Summary 79
14.1 Private Equity 79
14.1.1 Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 79
14.2 Partnerships 81
14.2.1 Intrinsic Bioprobes Enters Into Licensing Agreement With Ortho-Clinical Diagnostics 81
14.2.2 CeMines Enters Into An Agreement With Ortho-Clinical Diagnostics 82
14.2.3 20/20 GeneSystems Signs An Agreement With Ortho-Clinical Diagnostics 83
14.2.4 Roche Signs Licensing Agreement With Ortho-Clinical Diagnostics And Novartis Vaccines and Diagnostics 84
14.2.5 QIAGEN And Ortho-Clinical Diagnostics Enter Into Licensing Agreement 85
14.2.6 Bristol-Myers Squibb, Saladax Biomedical And Ortho-Clinical Diagnostics Expand Co-Development Agreement 86
14.2.7 Rapid Biosensor Announces Option Agreement With Ortho-Clinical Diagnostics 88
14.3 Asset Transactions 89
14.3.1 Streck Acquires SickleDex Product Line From Ortho-Clinical Diagnostics 89
15 Recent Developments 90
15.1 Product News 90
15.1.1 Jun 11, 2012: Ortho-Clinical Receives CE Mark For VITROS Immunodiagnostic Free PSA Assay 90
15.1.2 Jun 04, 2012: Ortho Clinical Diagnostics Receives CE Mark For Vitamin D Total Assay 90
15.1.3 Mar 28, 2012: Ortho-Clinical Announces Availability Of Avioq HTLV-I/II Microelisa System Assay 91
15.1.4 Mar 27, 2012: Avioq Receives FDA Approval For HTLV-I/II Microelisa System 91
15.1.5 Jul 22, 2011: Ortho Clinical Diagnostics Launches VITROS 4600 Chemistry System For Mid-To High-Volume Laboratories 92
15.1.6 Nov 01, 2010: Ortho Clinical Diagnostics Receives FDA 510(k) Clearance For VITROS Intact Parathyroid Hormone Assay 93
15.1.7 Nov 01, 2010: Ortho-Clinical Diagnostics Gets FDA Clearance For VITROS Intact Parathyroid Hormone (iPTH) Assay 93
15.1.8 Oct 26, 2009: Ortho Clinical Diagnostics Receives FDA Approval For VITROS Hepatitis B Surface Antigen (HBsAg) Assay 94
15.1.9 Oct 23, 2009: Ortho Clinical Diagnostics Introduces FETALSCREEN II Fetal Maternal Hemorrhage Screening Test 95
15.1.10 Oct 14, 2009: Ortho Clinical Diagnostics Announces FDA Approval For Diagnostic Assay For Detection Of HIV Types 1+2 For Use With VITROS 5600 Integrated And VITROS 3600 Immunodiagnostic Systems 95
15.1.11 Jul 21, 2009: Ortho Clinical Diagnostics Announces US FDA Approval Of The VITROS Anti-HCV Assay For Use On The VITROS 5600 Integrated And 3600 Immunodiagnostic Systems 96
15.1.12 Jan 15, 2009: Ortho Clinical Diagnostics Announces Availability Of Two Next Generation Clinical Diagnostic Platforms In Europe 96
15.1.13 Dec 23, 2008: Ortho Clinical’s VITROS 3600 Immunodiagnostic System Receives 510 (K) Clearance For Laboratory Diagnostics 97
15.1.14 Oct 01, 2007: Ortho-Clinical Diagnostics Introduces Improved Sensitivity Troponin I Assay 97
15.1.15 Jun 04, 2007: Ortho-Clinical Diagnostics Expands Infectious-Disease Test Menu With Launch of Toxoplasma IgM Assay 98
15.1.16 Jun 04, 2007: Ortho-Clinical Diagnostics Expands Infectious-Disease Test Menu With Launch of CMV IgG Assay 98
15.1.17 Jun 04, 2007: Ortho-Clinical Diagnostics Expands Infectious-Disease Test Menu With Launch of Rubella IgM Assay 99
15.2 Product Approvals 99
15.2.1 Jun 11, 2012: Ortho-Clinical Receives CE Mark For VITROS Immunodiagnostic Free PSA Assay 99
15.2.2 Jun 04, 2012: Ortho Clinical Diagnostics Receives CE Mark For Vitamin D Total Assay 99
15.2.3 Mar 27, 2012: Avioq Receives FDA Approval For HTLV-I/II Microelisa System 100
15.2.4 Nov 01, 2010: Ortho Clinical Diagnostics Receives FDA 510(k) Clearance For VITROS Intact Parathyroid Hormone Assay 101
15.2.5 Nov 01, 2010: Ortho-Clinical Diagnostics Gets FDA Clearance For VITROS Intact Parathyroid Hormone (iPTH) Assay 101
15.2.6 Oct 26, 2009: Ortho Clinical Diagnostics Receives FDA Approval For VITROS Hepatitis B Surface Antigen (HBsAg) Assay 102
15.2.7 Oct 14, 2009: Ortho Clinical Diagnostics Announces FDA Approval For Diagnostic Assay For Detection Of HIV Types 1+2 For Use With VITROS 5600 Integrated And VITROS 3600 Immunodiagnostic Systems 103
15.2.8 Oct 14, 2009: Ortho Clinical Diagnostics Announces FDA Approval For Diagnostic Assay For Detection Of HIV Types 1+2 For Use With VITROS 5600 Integrated And VITROS 3600 Immunodiagnostic Systems 103
15.2.9 Jul 21, 2009: Ortho Clinical Diagnostics Announces US FDA Approval Of The VITROS Anti-HCV Assay For Use On The VITROS 5600 Integrated And 3600 Immunodiagnostic Systems 104
15.2.10 Dec 23, 2008: Ortho Clinical’s VITROS 3600 Immunodiagnostic System Receives 510 (K) Clearance For Laboratory Diagnostics 105
15.3 Other Significant Developments 105
15.3.1 Mar 25, 2010: Ortho-Clinical Diagnostics To Break Ground On Solar Energy Installation At New Jersey Headquarters 105
16 Appendix 107
16.1 Research Methodology 108
16.2 Secondary Research 108
16.3 Primary Research 108
16.4 Models 109
16.5 Forecasts 109
16.6 Expert Panels 109
16.7 GlobalData Consulting 109
16.8 Currency Conversion 110
16.9 Contact Us 111
16.10 Disclaimer 111


【レポート販売概要】

■ タイトル:Ortho-Clinical Diagnostics Inc.:市場シェア分析
■ 英文:Ortho-Clinical Diagnostics Inc. Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160532
■ 調査対象地域:グローバル
  • 中国の家電市場:スマートフォン、パソコン、タブレット、ゲーム機、カメラ、テレビ
    Consumer electronics include all electronic devices that are intended for daily use and includes devices like smartphones, tablets, PCs, gaming consoles, TVs and cameras. Technavios market research analyst has estimated factors like the augmented sale of smartphones and gaming consoles in this region to bolster market growth during the forecast period, resulting in its healthy CAGR of around 10% b …
  • スマートガスのグローバル市場動向(2014-2019)
    The gas utility sector has been facing numerous challenges in the distribution of natural gas. Consumption of gas as an energy source is been on the rise due to expanding residential and commercial estates. The use of Smart Gas technology solutions offers an efficient and reliable solution to the utility industry to effectively reach and communicate with the exploding customer base. This technolog …
  • Cachexia:グローバル臨床試験レビューH1, 2013
    Cachexia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, H1, 2013" provides data on the Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
  • セラミック溶射技術の世界市場:ジルコニア系/アルミナ系/チタニア系/クロミア系セラミック溶射
    About Ceramic Coatings Thermal Spray Ceramic coatings thermal spray technology is used to provide thermal barrier protection, in the form of coatings, to various industrial components. It is used to prevent the wear and tear of components due to corrosion and erosion from working at extreme temperatures. It is applied by spraying molten coating particles onto a heated work-piece. Alumina, chromia, …
  • 同種幹細胞の世界市場:種類別、地域別
    Global Allogeneic Stem Cells Market: About this market Technavio’s allogeneic stem cells market analysis considers sales from regenerative therapy and drug discovery and development applications. Our study also finds the sales of allogeneic stem cells in Asia, Europe, North America, and ROW. In 2019, the regenerative therapy segment had a significant market share, and this trend is expected to con …
  • 腫瘍治療薬の中国市場:化学療法、標的療法、免疫療法、ホルモン療法
    The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 to 2026. Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer according to the data published by WHO. Being the most populous co …
  • マタニティ用下着の世界市場2017-2021
    About Maternity Intimate WearIntimate wear products are also known as lingerie. The intimate wear that is specifically made for use during maternity period is known as maternity intimate wear. Technavio’s analysts forecast the global maternity intimate wear market to grow at a CAGR of 3.27% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth …
  • 乾癬性関節炎治療法の世界市場:生物製剤、小分子
    Global Psoriatic Arthritis Therapeutics Market: About this market Psoriatic arthritis is an autoimmune disorder that primarily affects psoriasis patients, with approximately 30% of the patient population at risk. Technavio’s psoriatic arthritis therapeutics market analysis considers sales from both biologics and small molecules. Our analysis also considers the sales of psoriatic arthritis therapeu …
  • アンモニアの世界市場予測
    Ammonia 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about ammonia market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, the repo …
  • 外来用血圧モニターの世界市場2016-2020
    About the Ambulatory Blood Pressure Monitoring Systems Market Ambulatory blood pressure monitoring systems are portable devices that help measure and monitor the blood pressure in the human body. These devices obtain blood pressure readings for a set of time during a 24-hour period. The device records blood pressure readings every 20 minutes. It consists of an arm cuff attached to a lightweight mo …
  • 動力式芝刈り機の世界市場2016-2020
    About Power Lawn Mowers Power lawn mowers have evolved from the traditional hand-guided mowers to automatic electric mowers. Advancements in technology have led to the development of lightweight power lawn mowers and battery-powered lawn mowers. The robotic lawn mower is one such innovative product available in the market. Increasing availability of such products with improved features has contrib …
  • MRSA検査の世界市場2017-2021
    About MRSA testingMRSA has been a major cause of concern due to the long-term use of antibiotics, which is now deemed as unnecessary. The inappropriate use of antibiotics may contribute to the rise in drug-resistant bacteria because they do not destroy the bacteria completely. This has been one of the major factors influencing the use of MRSA testing in the medical industry. With this, there is fo …
  • 脊髄症(Myelopathy):グローバル臨床試験動向(2014年上半期)
    Myelopathy Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Myelopathy Global Clinical Trials Review, H1, 2014" provides data on the Myelopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myelopathy It includes an overview of the trial numbers and their recruitment status as per the site of tria …
  • 瘢痕治療の世界市場2016-2020
    About Scar Treatment A scar is a patch of fibrous tissue (containing a protein called collagen) that is formed over a wound as a consequence of the body's natural healing process. Scars are classified into keloid scars, contracture scars, hypertrophic scars, and atrophic scars based on the composition of collagen and appearance. Many non-invasive methods including chemical and physical treatment a …
  • 工業廃水処理装置の世界市場2015 -2019
    About Industrial Wastewater Treatment Equipment Industrial wastewater is one of the largest sources of pollution in aquatic environment. During the last century, a huge amount of industrial wastewater was discharged into water bodies, resulting into serious pollution issues and hazardous effects on ecosystem and human life. Industrial wastewater may differ depending on various industries and disch …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。